Company Monitoring Page for JNJ

latest headlines for company on cafepharma

J&J warns generics will bite its pharma unit in the second half
Pharmaforum
Wed, 07/17/19 - 09:49 am
Tags:
JNJ, generics, biosimilars, Darzalex, Zytiga
Xarelto falls into the donut hole
Biopharma Dive
Tue, 07/16/19 - 11:05 pm
Tags:
JNJ, Xarelto, Medicare
J&J (JNJ) Beats on Q2 Earnings, Ups 2019 Sales Growth View
Yahoo/Zacks.com
Tue, 07/16/19 - 11:04 am
Tags:
JNJ, earnings
All eyes on Oklahoma as J&J awaits $17bn opioid case verdict
Pharmaforum
Tue, 07/16/19 - 10:56 am
Tags:
JNJ, opioids, opioid crisis, Oklahoma
J&J gears up for clinical test of HIV vaccine efficacy
Fierce Biotech
Mon, 07/15/19 - 10:06 am
Tags:
JNJ, clinical trials, HIV, vaccines
The Week Ahead In Biotech: Johnson & Johnson Kickstarts Big Pharma Earnings
Yahoo/Benzinga
Sun, 07/14/19 - 04:09 pm
Tags:
Merck, relebactam, TapImmune, earnings, JNJ, Seattle Genetics, Abbott Labs, Intuitive Surgical, Mirum Pharmaceuticals, Fulcrum Therapeutics, Genmab
Pharma Stock Roundup: Pipeline & Regulatory Updates by MRK, GSK, SNY
Yahoo/Zacks.com
Sat, 07/13/19 - 11:34 am
Tags:
GSK, HIV, FDA, Merck, Keytruda, Sanofi, isatuximab, Roche, JNJ
J&J Stock Dives As Feds Reportedly Seek Criminal Probe Into Talc Powders
Investors Business Daily
Sat, 07/13/19 - 11:18 am
Tags:
JNJ
J&J earnings preview: Wall Street is still optimistic despite company’s legal issues
Marketwatch
Thu, 07/11/19 - 09:57 am
Tags:
JNJ, earnings
Hunting better biomarkers, J&J taps Celsius to unpack role played by single cells
Biopharma Dive
Tue, 07/9/19 - 11:55 am
Tags:
JNJ, Celsius Therapeutics, biomarkers, inflammatory bowel disease
Bayer/J&J eye new pediatric use for anticoagulant Xarelto
Pharmaforum
Tue, 07/9/19 - 08:47 am
Tags:
Bayer, JNJ, Xarelton, pediatrics
J&J dumps Hanmi obesity drug following midphase trials
Fierce Biotech
Mon, 07/8/19 - 10:51 am
Tags:
JNJ, HM12525A, obesity, Hanmi Pharmaceutical
FDA quickly approves J&J’s Darzalex in multiple myeloma
Pharmaforum
Fri, 06/28/19 - 12:32 pm
Tags:
JNJ, Janssen, FDA, Darzalex, Multiple Myeloma
J&J depression drug Spravato gets half-hearted backing from VA doctors despite Trump's zeal
Fierce Pharma
Mon, 06/24/19 - 07:21 pm
Tags:
JNJ, Spravato, Veteran's Affairs, Donald Trump, depression
Cost-effectiveness watchdogs skewer Novartis' MS drug Mayzent and J&J's depression spray Spravato
Fierce Pharma
Fri, 06/21/19 - 11:33 pm
Tags:
Novartis, Mayzent, JNJ, Spravato, ICER
J&J's Ethicon and Spain's Grifols Release 1st Product Out of 10-Year Collaboration Deal
BioSpace
Thu, 06/20/19 - 08:44 pm
Tags:
JNJ, Ethicon, Grifols, Vistaseal, surgical bleeding
Janssen’s guselkumab succeeds in phase 3 psoriatic arthritis trials
Pharmaceutical Business Review
Tue, 06/18/19 - 11:38 pm
Tags:
JNJ, Janssen, Tremfya, clinical trials, psoriatic arthritis
Janssen Eyes Another Approval for Tremfya After Hitting Trial Endpoints
BioSpace
Fri, 06/14/19 - 06:23 pm
Tags:
JNJ, Janssen, clinical trials, Tremfya, psoriatic arthritis
Johnson & Johnson takes a $4.8M hit in talc case, but once again pledges to appeal
Fierce Pharma
Thu, 06/13/19 - 11:55 am
Tags:
JNJ
J&J gains an enthusiastic endorsement from President Donald Trump for their big new drug Spravato
Endpoints
Thu, 06/13/19 - 10:00 am
Tags:
Donald Trump, JNJ, Spravato, depression, veterans

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.